Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 14, 2024 07:05 ET | Source: Codexis, Inc.

Codexis Announces New Employment Inducement Grants

REDWOOD CITY, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...
October 10, 2024 16:05 ET | Source: Codexis, Inc.

Codexis to Report Third Quarter 2024 Financial Results on October 31

REDWOOD CITY, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...
October 02, 2024 16:05 ET | Source: Codexis, Inc.

Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company

Company raises $31 million through ATM, bringing cash runway into 2027 New additions to leadership in technical operations, finance and intellectual property prepare Codexis for the next phase of...
October 01, 2024 07:05 ET | Source: Codexis, Inc.

Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences

REDWOOD CITY, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has entered into a non-exclusive commercial and...
September 06, 2024 16:05 ET | Source: Codexis, Inc.

Codexis Announces New Employment Inducement Grants

REDWOOD CITY, Calif., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to three new employees as...
September 03, 2024 16:05 ET | Source: Codexis, Inc.

Codexis to Participate in Upcoming Healthcare Conferences

REDWOOD CITY, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that management will participate in two upcoming investor...
August 20, 2024 16:05 ET | Source: Codexis, Inc.

Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting

REDWOOD CITY, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will participate in a presentation and panel...
August 16, 2024 16:05 ET | Source: Codexis, Inc.

Codexis Announces New Employment Inducement Grants

REDWOOD CITY, Calif., Aug. 16, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to three new employees as...
August 15, 2024 16:05 ET | Source: Codexis, Inc.

Codexis Publishes FY2023 Sustainability Disclosures

REDWOOD CITY, Calif., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the publication of its inaugural sustainability...
August 08, 2024 16:05 ET | Source: Codexis, Inc.

Codexis Reports Second Quarter 2024 Financial Results

Company Reiterates Full-year Financial Guidance; On Track to Achieve Product Revenue Growth of at Least 10% vs. FY2023 Excluding Enzyme Sales Related to PAXLOVID™ Anticipate Entering First Technical...